What is Erlotinib?
CATEGORY: Prescription Drugs
Erlotinib is an orally administered medication that can be used to treat locally advanced or metastatic EGFR positive non-small cell lung cancer (NSCLC). It can also be used in combination with gemcitabine as a first-line treatment for locally advanced, unresectable, or metastatic pancreatic cancer.
Save up to 80% off your prescriptions!
How do members experience Erlotinib?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 209 | 23 | |
| Non-small cell lung cancer | 55 | 2 | |
| Lung cancer | 16 | 3 | |
| Squamous cell carcinoma (non-small cell lung cancer) | 9 | 0 | |
| Adenosquamous carcinoma (non-small cell lung cancer) | 8 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Diarrhea | 13 | |
| Dry skin | 4 | |
| Rashes (redness, swelling) | 4 | |
| Fatigue | 3 | |
| Rash on face | 3 | |
| Acne breakout | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 6 | |
| Moderate | 10 | |
| Mild | 12 | |
| None | 2 |
Learn more about our community’s experience with Erlotinib
What are people saying about Erlotinib?
358
358
members have reported taking Erlotinib
Join the conversation and connect with people who have taken Erlotinib
Last updated: